Physician

Dhatri Kodali, MD

According to 2025 Medicare claims, Dhatri Kodali, MD (NPI: 1477745800) practices hematology/oncology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Galveston, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1821265265; TIN: 752131429) and primary practice location at 77598-4219.

Kodali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 736 traditional Medicare patients, billed 147,351 HCPCS/CPT codes, and received $2,180,810 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,657 prescription claims across 348 beneficiaries totaling $3,960,953 in drug costs, led by Revlimid (Lenalidomide). DME data shows 12 claims. Open Payments data shows 26 records totaling $249,110. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,080,578 to $2,180,810. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	504	153,569	$1,080,578
2016	670	200,139	$1,648,708
2017	731	140,339	$1,347,859
2018	682	88,715	$1,122,928
2019	723	163,162	$1,942,120
2020	608	117,012	$1,711,140
2021	636	138,899	$1,823,492
2022	684	130,562	$1,932,760
2023	758	136,334	$1,830,490
2024	736	147,351	$2,180,810

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	162	1,244	$1,421,408
2016	211	1,576	$1,744,905
2017	221	1,392	$1,847,001
2018	230	1,542	$2,225,706
2019	249	1,681	$1,672,114
2020	250	1,566	$1,969,650
2021	269	1,198	$1,669,662
2022	283	1,391	$2,085,622
2023	311	1,363	$1,948,793
2024	348	1,657	$3,960,953

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	111	$29,851
2016	N/R	22	$16,716
2017	N/R	N/R	N/R
2018	N/R	33	$4,714
2019	N/R	11	$873
2020	N/R	44	$4,306
2021	N/R	28	$2,608
2022	N/R	N/R	N/R
2023	N/R	69	$32,979
2024	N/R	12	$525

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	424	708	$91
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	279	383	$11
80053	Blood test, comprehensive group of blood chemicals	421	977	$10
36415	Insertion of needle into vein for collection of blood sample	433	1,192	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	430	1,147	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	39	1,092	$787,635
Verzenio	Abemaciclib	29	812	$440,550
Kisqali	Ribociclib Succinate	21	588	$295,633
Lenalidomide	Lenalidomide	19	534	$277,384
Erleada	Apalutamide	16	480	$235,638

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	12	$525

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$452	ARRAY BIOPHARMA INC
Research Payments	Reported research-related payment or transfer-of-value amount.	6	$248,659	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dhatri Kodali, MD?

Tedicare shows public-source Medicare data for Dhatri Kodali, MD (NPI 1477745800), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dhatri Kodali, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Dhatri Kodali, MD?

Dhatri Kodali, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1821265265) in the available physician profile data.

Does Dhatri Kodali, MD have Open Payments data?

Dhatri Kodali, MD has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.